fashion -WSS

fashion

author：entertainment 2025-08-28 03:32:26 - browse：4885

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： UCSF medical school apologizes for unethical prisoner experiments

focus

WSS

Victims of gun violence feel impacts long after bullet wound

Lilly’s weekly insulin works as well as daily products, new studies show

MoonLake credibility takes another hit with mid

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

What a koala virus tells us about the human genome

explore

fashion

explore

Alkermes shareholders re

Medicare solvency divides Republicans at the presidential debate

In Memoriam: Notable people who died in 2023

To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

Alkermes shareholders re

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

How one medical school became remarkably diverse

Removing probiotics from the NICU could threaten preemies' health

State Dept. review finds Biden bears some blame for Afghanistan failures

Will General Catalyst be the first of many hospital takeovers?

hotspot

Victims of gun violence feel impacts long after bullet wound

Removing probiotics from the NICU could threaten preemies' health

Cherokee Nation medical school graduates its first class

Extreme heat events are a public health emergency

Obesity drug from Roche shows promise in early study

Ambulance rides for just $100? Advisers want major billing fixes

focus

focus

knowledge

entertainment